Fagan Associates’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,092
Closed -$242K 136
2025
Q2
$242K Hold
3,092
0.04% 117
2025
Q1
$224K Sell
3,092
-800
-21% -$57.3K 0.04% 119
2024
Q4
$288K Sell
3,892
-580
-13% -$40.6K 0.05% 120
2024
Q3
$295K Hold
4,472
0.05% 115
2024
Q2
$413K Sell
4,472
-205
-4% -$18.2K 0.07% 97
2024
Q1
$447K Hold
4,677
0.08% 98
2023
Q4
$357K Hold
4,677
0.08% 92
2023
Q3
$324K Sell
4,677
-48
-1% -$3.86K 0.08% 93
2023
Q2
$446K Hold
4,725
0.11% 84
2023
Q1
$391K Buy
4,725
+48
+1% +$3.77K 0.1% 93
2022
Q4
$349K Hold
4,677
0.09% 99
2022
Q3
$386K Hold
4,677
0.11% 92
2022
Q2
$445K Hold
4,677
0.12% 89
2022
Q1
$551K Hold
4,677
0.11% 96
2021
Q4
$606K Hold
4,677
0.12% 93
2021
Q3
$529K Sell
4,677
-80
-2% -$9.13K 0.12% 94
2021
Q2
$493K Buy
4,757
+1,256
+36% +$118K 0.11% 100
2021
Q1
$293K Sell
3,501
-34
-1% -$2.87K 0.07% 110
2020
Q4
$322K Sell
3,535
-100
-3% -$8.29K 0.08% 101
2020
Q3
$290K Sell
3,635
-100
-3% -$7.8K 0.08% 96
2020
Q2
$258K Hold
3,735
0.08% 96
2020
Q1
$235K Sell
3,735
-210
-5% -$15.1K 0.09% 94
2019
Q4
$307K Hold
3,945
0.1% 103
2019
Q3
$289K Hold
3,945
0.11% 101
2019
Q2
$243K Hold
3,945
0.1% 106
2019
Q1
$252K Hold
3,945
0.11% 103
2018
Q4
$201K Hold
3,945
0.1% 105
2018
Q3
$229K Sell
3,945
-192
-5% -$9.39K 0.09% 110
2018
Q2
$201K Buy
+4,137
New +$193K 0.09% 111

Other funds holding EW